## EFX: Equifax Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 -3.5% below STRENGTH zone (3.0-6.0%); PEG 1.00 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.3% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($201.38)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 8
- **Sentiment:** Neutral (Bullish: 0, Bearish: 2)

**1. Equifax (NYSE:EFX) Shares Gap Down - What's Next?**
- Source: MarketBeat | 20260106T172556 | Somewhat-Bearish | Relevance: 100%
- Equifax (NYSE:EFX) experienced a premarket gap down, opening at $213.10 compared to its previous close of $220.79, and was trading around $208.52, a decline of approximately 5.2%. Analysts generally rate the stock as a "Moderate Buy" with varied price targets, ranging from Stifel's cut to $253 to UBS's raise to $297. The company recently beat Q3 earnings estimates and issued guidance for Q4 2025 and FY2025, while insider selling totaled about 54,270 shares over the last three months.

**2. Equifax (EFX) Faces Scrutiny Over Pricing Models, Shares Fall**
- Source: GuruFocus | 20260106T143055 | Bearish | Relevance: 100%
- Equifax (EFX) shares dropped 2.3% in premarket trading after the Federal Housing Finance Agency criticized the pricing strategies of credit reporting companies. Despite current stock declines, Equifax maintains strong financial health, indicated by robust margins and a solid balance sheet, yet faces ongoing regulatory scrutiny and some insider selling. The company's valuation metrics suggest potential undervaluation, and analyst sentiment remains positive.

**3. Equifax, TransUnion stocks dip after Pulte comments on credit bureaus (EFX:NYSE)**
- Source: Seeking Alpha | 20260106T125857 | Bearish | Relevance: 100%
- Equifax (EFX) and TransUnion (TRU) stocks saw dips in premarket trading after Federal Housing Finance Agency Director Bill Pulte reiterated his criticism of credit reporting companies' pricing models. This renewed scrutiny on credit bureaus led to declines of 2.3% for Equifax and 2.5% for TransUnion.

**4. BNP Paribas Exane Adjusts Price Target on Equifax to $250 From $240, Maintains Neutral Rating**
- Source: marketscreener.com | 20260105T121822 | Somewhat-Bullish | Relevance: 100%
- BNP Paribas Exane has raised its price target for Equifax (NYSE: EFX) to $250 from $240, while reaffirming a Neutral rating on the stock. This adjustment comes amidst other analyst actions on Equifax, with Autonomous Research also adjusting its price target on the same day. The article provides recent news and analyst consensus regarding Equifax's performance and future outlook.

**5. GAM Holding AG Takes Position in Equifax, Inc. $EFX**
- Source: MarketBeat | 20260104T111357 | Somewhat-Bullish | Relevance: 100%
- GAM Holding AG has acquired a new stake of 7,046 shares in Equifax (NYSE:EFX) during Q3, valued at approximately $1.81 million. Equifax surpassed Q3 estimates with $2.04 EPS and $1.54 billion in revenue, also providing strong Q4 2025 and full-year 2025 guidance. While insiders have sold shares, institutional investors hold a significant 96.2% of the company's stock, and analysts maintain a "Moderate Buy" rating.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Morgan Stanley | $280 | $290 | -3% |
| 2025-12-08 | BMO Capital | $234 | $245 | -4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Morgan Stanley | main | Overweight |
| 2025-12-08 | BMO Capital | main | Market Perform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 1 ($0.86M) |
| Sells | 5 ($1.53M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 53.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.5% (+2.1%)
- Capital Internationa: 8.5% (-0.4%)
- Blackrock Inc.: 7.5% (+1.4%)
- Price (T.Rowe) Assoc: 4.9% (+1.0%)
- Harris Associates L.: 4.8% (+14.2%)

### Key Risks

1. Momentum deterioration: MRS_10 falling (-3.3% 5d) with bearish MACD, trend may be turning.
2. Long-term trend broken: trading 11.9% below SMA200.
3. Market regime shift could impact high-beta names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.00 suggests fair value with growth premium. Analyst sentiment negative (2 target cuts vs 0 raises). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $26.1B |
| Beta | 1.56 |
| 52W Range | $199.98 - $281.07 |
| Short Interest | 3.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.00 |
| Forward P/E | 24.1 |
| Current P/E | 27.9 |
| YoY Growth | 15.7% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from -0.1% to -3.5% (-3.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 6.5pp (needs >3.0% for momentum thesis). Underperforming sector by 6.3pp, stock-specific weakness. Below SMA200 (0.88x), long-term trend not supportive. MACD histogram bearish (-0.53), momentum weakening. RSI neutral at 43. OFD pattern: -SLH (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -3.46% (CS: 7) | Weak |
| RSI_14 | 43.2 | Neutral |
| MACD Histogram | -0.53 | Bearish |
| vs SMA20 | 0.974x | Below |
| vs SMA50 | 0.992x | Below |
| vs SMA200 | 0.881x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $212.30
- **Stop Loss:** $201.38 (5.1% risk)
- **Target:** $223.22 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 120
- **Position Value:** $25,476.00
- **Portfolio %:** 25.48%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | RISK_ON (MEDIUM) | 1.10x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*RISK_ON regime with strong participation and low volatility. VIX at 14.75 (6th percentile) with breadth at 63.5% signals healthy risk appetite. Fed dovish expectations and AI/semiconductor momentum are primary drivers, though elevated put/call ratio suggests smart money hedging. Focus on quality growth with awareness of potential complacency.*

### Earnings

**Next:** 2026-02-05 (Est: $2.04)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.94 | $2.04 | +5.3% |
| 2025Q2 | $1.92 | $2.00 | +4.1% |
| 2025Q1 | $1.40 | $1.53 | +9.0% |
| 2024Q4 | $2.10 | $2.12 | +1.1% |

---
*RULE-based L3 | 2026-01-07 08:25 | MRS_10*